Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Cerliponase alfa (neuronale zeroidlipofuszinose typ 2): bewertung gemäß § 35a Abs. 1 Satz 10 SGB V; dossierbewertung; auftrag G17-06. [Cerliponase alfa (neuronal ceroid lipofuscinosis) - assessment according to §35a (para. 1., sentence 10) Social Code Book V] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 542. 2017 Indexing Status Subject indexing assigned by CRD MeSH Brain; Humans; Neuronal Ceroid-Lipofuscinoses Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32017000413 Date abstract record published 06/11/2017 |